Larry Fink urges regulatory clarity to advance blockchain-based asset tokenization, signaling progress toward market adoption. BlackRock CEO Larry Fink has intensified calls for SEC regulations enabling tokenized securities, a process converting traditional assets like sto
The synthetic biology firm projects $125M-$150M in cash burn for FY26, spooking investors and dragging shares lower. Ginkgo Bioworks (DNA) shares fell nearly 14% after the company forecast FY26 cash burn of $125M to $150M in its first-quarter results. The stock traded at $
The e-commerce software firm targets FX-neutral mid-single-digit subscription growth and low-20s margins for operating and free cash flow in 2026. VTEX projected mid-single-digit subscription revenue growth for 2026 on a foreign-exchange-neutral basis during its Q1 2026 ea
The coal producer reaffirmed its full-year cost guidance after reporting $30 million in Q1 2026 adjusted EBITDA. Alpha Metallurgical Resources maintained its 2026 cost guidance range of $95 to $101 per ton, citing resilience against inflation tied to Iran-related supply ch
The stock market ran to all-time highs on the S&P 500, Nasdaq and Russell 2000 during the week as crude oil prices tumbled on Iran deal hopes and another wave of generally strong earnings. AI leaders hit a speed bump Thursday, as crude futures steadied somewhat, but ramped
Corpay’s Q1 revenue surged 25 percent to $1.26 billion, with adjusted EPS of $5.80, prompting a full-year outlook increase. Corpay reported first-quarter revenue growth of 25 percent year over year to $1.26 billion, while adjusted earnings per share rose to $5.80, exceedin
Sellers emerged as the currency pair failed to break above critical technical levels following mixed US and Canadian jobs data. USDCAD climbed to a session high of 1.3710 after stronger-than-expected US jobs data contrasted with weaker Canadian employment figures. The pair
The biotech firm reported a GAAP loss per share of $0.32, wider than expected, as cash reserves declined quarter-over-quarter. Camp4 Therapeutics posted a first-quarter GAAP loss per share of $0.32, missing estimates by $0.11. The wider-than-expected loss reflects ongoing
IonQ reported Q1 2026 revenue of $64.7 million, up 755% year-over-year, prompting a price target increase from $37 to $47. IonQ posted record Q1 2026 revenue of $64.7 million, surging 755% from the prior year, as demand for its quantum computing platform accelerated. Remai
The latest monthly list of new buys by the best mutual funds shows massive demand for Google parent Alphabet (GOOGL) and Broadcom (AVGO). But that reveals just the tip of the institutional investor iceberg Micron Technology (MU), Analog Devices (ADI), Arista Network
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.